Aline Moreau

Title: Aline Moreau: Innovator in Pharmaceutical Compositions

Introduction

Aline Moreau is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory conditions. With a total of 2 patents, her work focuses on innovative solutions for bronchopulmonary pathologies.

Latest Patents

Aline Moreau's latest patents include an EGF-containing pharmaceutical composition aimed at treating bronchopulmonary pathologies accompanied by lesions of the bronchial epithelium. This composition utilizes Epidermal Growth Factor (EGF) to enhance healing. Additionally, she has developed methods for treating disorders of the upper and lower airways, which involve dehydration of the respiratory epithelium and hyperadhesion of mucus. These methods utilize adenosine 5'-triphosphate disodium salt or uridine 5'-triphosphate, either alone or in combination with amiloride.

Career Highlights

Throughout her career, Aline Moreau has worked with notable organizations such as Synthelabo and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Aline has collaborated with esteemed colleagues, including Edith Puchelle and Rachid Benali. These partnerships have fostered a collaborative environment that enhances innovation in her field.

Conclusion

Aline Moreau's contributions to pharmaceutical innovations demonstrate her commitment to improving respiratory health. Her patents reflect her dedication to developing effective treatments for complex medical conditions.